Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/pathology.3.033
Can Artificial Intelligence Help?
- 1Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill Univ, Montreal, Canada
- 2Department of Surgery, Wonju Severance Christian Hospital, Yonsei University, Wonju College of Medicine, South Korea
- 3Center for Bio-Medical Engineering Core Facility, Dankook University, Cheonan, South Korea
- 4Department of Biomedical Science and Engineering (BMSE), Gwangju Institute of Science and Technology (GIST), Gwangju, South Korea
- 5Department of Pathology, College of Medicine, Dankook University, Cheonan, South Korea
Yong-Moon Lee, firstname.lastname@example.org
Received Date: January 27, 2022
Accepted Date: April 07, 2022
Nguyen TD, Park JH, Han K, Lee B, Lee Y-M. Can Artificial Intelligence Help!. J Exp Pathol. 2022;3(1):12-15.
Copyright: © 2022 Nguyen TD, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
DILI, HILI, RUCAM Algorithm, and AI, the Artificial Intelligence: Provocative issues, Progress, and Proposals
Artificial Intelligence (AI) techniques represent a fascinating, provocative, and challenging discipline, are pervasive and of global importance. The European Commission summarized the current state in a White Paper on AI issues released on 19 February 2020, discussing various AI concepts that revolutionized many complex processes
Artificial Intelligence and Machine Learning in Cancer Care: Current Applications and Future Perspectives
Cancer is the second most common cause of death worldwide, accounting for an estimated 9.6 million deaths in the year 2018, a number that is expected to grow to more than 13 million by 2030. In the past decade, we have witnessed unprecedented scientific advancement in the understanding of cancer etiology, prevention, diagnosis and development of new therapeutic strategies.
Artificial Intelligence in Pharma: Positive Trends but More Investment Needed to Drive a Transformation
Over the past few years, pharmaceutical R&D has become aware of the potential benefits of leveraging artificial intelligence and its collective subfields including machine learning, deep learning, data science and advanced analytics.
Gadolinium-based contrast agents (GBCAs) work by shortening the T1, T2, and T2* relaxation time constants of adjacent water protons in tissues.
Papillary thyroid carcinoma (PTC) is the fifth most common malignant tumor in women worldwide and the most common cancer in women younger than 25 years . Fortunately, the first is that the prognosis is excellent compared to other malignant tumors .